article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Though the Canada-based authors conclude that transdermal delivery of CBD shows great promise and represents a potential novel treatment for chronic inflammatory pain, they also acknowledge that the jury is still out on its ability to achieve that key benchmark of offering tangible clinical benefits. A killer app for pain? Haffar, Amer et al.,

Topical 158
article thumbnail

Medical Marijuana: An Alternative Treatment for Depression?

FloridaMarijuana.net

Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results. The post Medical Marijuana: An Alternative Treatment for Depression? appeared first on.

Treatment 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WSU researchers team with Puyallup tribe on medicinal cannabis research

Cannabis Chronicles

The partnership between the land grant institution in Pullman and the Tacoma-based native tribe is intended to create a standard to evaluate treatment plans at a natural healing clinic the Puyallups opened in October, and to determine the effectiveness of the drug as an alternative to opioids in managing pain.

Medicine 140
article thumbnail

Microdosing Collective Launches Around Safe and Regulated Access to Sub-Perceptible Doses of Psychedelics

Cannabis Law Report

The Microdosing Collective (“Microdosing Collective” or “the Collective”) is a new initiative supporting education around regulatory policy to permit legal microdosing for optimal wellbeing. The Collective estimates at least 600,000 people in the U.S. We seek to change that.”. actively microdose psychedelic medicines.

article thumbnail

U.S. regulators plan hearing on growing use of CBD in products

Cannabis Chronicles

regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. It also said any products that make drug or treatment claims also need to be approved by the FDA. NEW YORK — U.S.

CBD 113
article thumbnail

Survey: Nearly One in Five Pediatric Cerebral Palsy Patients Use CBD

Veriheal

Treatment plans are customized to each individual’s needs. Instead of directly surveying the young patients, they reached out to their caregivers – the individuals who deeply understand the daily routines, challenges, and treatments of these children.

Patients 116
article thumbnail

MedXtractor Fills a Key Gap in Mental Health Treatments

Cannabis Law Report

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Even if there’s an accurate diagnosis, many mental health treatments have less-than-desirable efficacy, and there can be significant side effects.